Search hospitals > Wisconsin > Rhinelander
Ascension Saint Mary's Hospital
Claim this profileRhinelander, Wisconsin 54501
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Ovarian Cancer
106 reported clinical trials
5 medical researchers
Summary
Ascension Saint Mary's Hospital is a medical facility located in Rhinelander, Wisconsin. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Ovarian Cancer and other specialties. Ascension Saint Mary's Hospital is involved with conducting 106 clinical trials across 217 conditions. There are 5 research doctors associated with this hospital, such as Andrew J. Huang, Jonathan S. Treisman, Christopher S. Platta, and Francis J. Cuevas.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 positive
PR positive
2Lung Cancer
Global LeaderStage III
Stage IV
Stage II
Top PIs
Andrew J. HuangAspirus Regional Cancer Center2 years of reported clinical research
Expert in Breast Cancer
Expert in Lung Cancer
68 reported clinical trials
141 drugs studied
Jonathan S. TreismanAscension Saint Elizabeth Hospital6 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
15 reported clinical trials
32 drugs studied
Christopher S. PlattaAspirus Regional Cancer Center7 years of reported clinical research
Studies Prostate Cancer
Studies Lung Cancer
12 reported clinical trials
38 drugs studied
Francis J. CuevasAscension Southeast Wisconsin Hospital - Elmbrook Campus8 years of reported clinical research
Studies Colorectal Cancer
Studies Lung Cancer
11 reported clinical trials
24 drugs studied
Clinical Trials running at Ascension Saint Mary's Hospital
Lung Cancer
Prostate Cancer
Esophageal cancer
Breast Cancer
Bladder Cancer
Gastric cancer
Colorectal Cancer
Esophageal Cancer
Stomach Cancer
Cancer
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Ascension Saint Mary's Hospital?
Ascension Saint Mary's Hospital is a medical facility located in Rhinelander, Wisconsin. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Ovarian Cancer and other specialties. Ascension Saint Mary's Hospital is involved with conducting 106 clinical trials across 217 conditions. There are 5 research doctors associated with this hospital, such as Andrew J. Huang, Jonathan S. Treisman, Christopher S. Platta, and Francis J. Cuevas.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.